Literature DB >> 10623740

A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids.

S D Parker1, E Hunter.   

Abstract

Retrovirus assembly involves a complex series of events in which a large number of proteins must be targeted to a point on the plasma membrane where immature viruses bud from the cell. Gag polyproteins of most retroviruses assemble an immature capsid on the cytoplasmic side of the plasma membrane during the budding process (C-type assembly), but a few assemble immature capsids deep in the cytoplasm and are then transported to the plasma membrane (B- or D-type assembly), where they are enveloped. With both assembly phenotypes, Gag polyproteins must be transported to the site of viral budding in either a relatively unassembled form (C type) or a completely assembled form (B and D types). The molecular nature of this transport process and the host cell factors that are involved have remained obscure. During the development of a recombinant baculovirus/insect cell system for the expression of both C-type and D-type Gag polyproteins, we discovered an insect cell line (High Five) with two distinct defects that resulted in the reduced release of virus-like particles. The first of these was a pronounced defect in the transport of D-type but not C-type Gag polyproteins to the plasma membrane. High Five cells expressing wild-type Mason-Pfizer monkey virus (M-PMV) Gag precursors accumulate assembled immature capsids in large cytoplasmic aggregates similar to a transport-defective mutant (MA-A18V). In contrast, a larger fraction of the Gag molecules encoded by the M-PMV C-type morphogenesis mutant (MA-R55W) and those of human immunodeficiency virus were transported to the plasma membrane for assembly and budding of virions. When pulse-labeled Gag precursors from High Five cells were fractionated on velocity gradients, they sedimented more rapidly, indicating that they are sequestered in a higher-molecular-mass complex. Compared to Sf9 insect cells, the High Five cells also demonstrate a defect in the release of C-type virus particles. These findings support the hypothesis that host cell factors are important in the process of Gag transport and in the release of enveloped viral particles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623740      PMCID: PMC111598          DOI: 10.1128/jvi.74.2.784-795.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Identification of retrovirus matrix proteins by lipid-protein cross-linking.

Authors:  R B Pepinsky; V M Vogt
Journal:  J Mol Biol       Date:  1979-07-15       Impact factor: 5.469

Review 2.  Proteolytic processing and particle maturation.

Authors:  V M Vogt
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

3.  Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.

Authors:  A G Fisher; L Ratner; H Mitsuya; L M Marselle; M E Harper; S Broder; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1986-08-08       Impact factor: 47.728

4.  Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus.

Authors:  P Sonigo; C Barker; E Hunter; S Wain-Hobson
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

5.  An electron microscopic study of moderate and virulent virus-cell interactions of the parainfluenza virus SV5.

Authors:  R W Compans; K V Holmes; S Dales; P W Choppin
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

6.  Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates.

Authors:  P Spearman; L Ratner
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational proteins modification.

Authors:  L E Henderson; H C Krutzsch; S Oroszlan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products.

Authors:  J Bradac; E Hunter
Journal:  Virology       Date:  1984-10-30       Impact factor: 3.616

10.  Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.

Authors:  H R Gelderblom; E H Hausmann; M Ozel; G Pauli; M A Koch
Journal:  Virology       Date:  1987-01       Impact factor: 3.616

View more
  8 in total

1.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy.

Authors:  S D Parker; J S Wall; E Hunter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly.

Authors:  S W Eastman; M L Linial
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Analysis of Mason-Pfizer monkey virus Gag domains required for capsid assembly in bacteria: role of the N-terminal proline residue of CA in directing particle shape.

Authors:  M Rumlova-Klikova; E Hunter; M V Nermut; I Pichova; T Ruml
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

7.  Characterization of producer cell-dependent restriction of murine leukemia virus replication.

Authors:  Fatima Serhan; Nathalie Jourdan; Sylvie Saleun; Philippe Moullier; Ghislaine Duisit
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus.

Authors:  Zdena Kohoutová; Michaela Rumlová; Martin Andreánsky; Michael Sakalian; Eric Hunter; Iva Pichová; Tomás Ruml
Journal:  Virology       Date:  2008-12-04       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.